Markers of Appetite Regulation During Exogenous Ketosis
NCT ID: NCT04156477
Last Updated: 2019-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2019-10-24
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
NCT05917873
The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals
NCT05273411
Metabolomic Signature of Exogenous Ketosis
NCT05699707
Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults
NCT05390385
How Orally Consumed 3-hydroxybuturate Alters Metabolism
NCT02917252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects are studied for five hours with baseline and blood sampling on multiple occasions. A satiety questionaire are included.
Subjects are recruited through notice on website for this purpose. Sample size calculations were performed prior to inclusion (n=10). According to protocolized statistical plan, missing data will not be replaced and no imputation will occur. Data will be analyzed by applying a repeated measurements multilevel model with intervention, time and their interactions as categorical factors. Effects size are adjusted for small sample size.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketone ester
Intake of a ketogenic drink.
Ketone ester
Intake of weight adjusted drink of a ketone ester
Isocaloric and -volumetric glucose drink
Intake of a taste matched glucogenic drink.
Glucose
Isocaloric and - volumetric taste adjusted drink
Isovolumetric tap water drink
Intake of a taste matched tap water drink.
Tap water
Isovolumetric taste adjusted tap water (placebo)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketone ester
Intake of weight adjusted drink of a ketone ester
Glucose
Isocaloric and - volumetric taste adjusted drink
Tap water
Isovolumetric taste adjusted tap water (placebo)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 20-35 kg/m2
* Expected ease of catheter insertion
* Oral and written informed consent
Exclusion Criteria
* Inability to cooperate to the trial
* Any electrolyte disorders, kidney disease or otherwise compromised renal function including excess risk hereof, e.g. hypertension, albuminuria, autoimmune disease, family history of kidney disease
* Any liver or bile disease including excess risk hereof, e.g. hepatotoxic drugs, alcohol abuse disorder, gallstones, pancreatitis, autoimmune disease, family history of liver disease
* Diabetes mellitus or any metabolic and/or hormonal disease including diagnosed/undiagnosed reactive hypoglycemia or similar disorders. This includes treatment with drugs, dietary supplement with inference on key metabolic or hormonal markers, e.g. insulin, glukagon, lipids, and GLP-1
* Any use of illegal or otherwise use of medicinal products without prescription
* Anemia or other know disease of the hematopoietic system
* Previous bariatric surgery
* Previous myocardial infarction or uncontrolled myocardial ischemia
* Recent intended/unintended weight loss
* Allergies to catheters or adhesives
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Jutland Regional Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik H Thomsen, M.D., PhD
Role: PRINCIPAL_INVESTIGATOR
Viborg Region Hospital, Central Jutland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regionshospitalet Viborg
Viborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Laeger T, Metges CC, Kuhla B. Role of beta-hydroxybutyric acid in the central regulation of energy balance. Appetite. 2010 Jun;54(3):450-5. doi: 10.1016/j.appet.2010.04.005. Epub 2010 Apr 21.
Stubbs BJ, Cox PJ, Evans RD, Santer P, Miller JJ, Faull OK, Magor-Elliott S, Hiyama S, Stirling M, Clarke K. On the Metabolism of Exogenous Ketones in Humans. Front Physiol. 2017 Oct 30;8:848. doi: 10.3389/fphys.2017.00848. eCollection 2017.
Myette-Cote E, Neudorf H, Rafiei H, Clarke K, Little JP. Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals. J Physiol. 2018 Apr 15;596(8):1385-1395. doi: 10.1113/JP275709. Epub 2018 Mar 2.
Svart M, Rittig N, Luong TV, Gopalasingam N, Vestergaard ET, Gormsen L, Sondergaard E, Thomsen HH, Gravholt CH. Three Weeks on a Ketogenic Diet Reduces Free Testosterone and Free Estradiol in Middle-Aged Obese Men and Women. J Nutr Metab. 2024 Aug 6;2024:9301369. doi: 10.1155/2024/9301369. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
121953
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.